Analysis of 7 RCTs: Dupilumab treatment reduces hospitalizations in adults with moderate-to-severe atopic dermatitis.

Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis – The Journal of Allergy and Clinical Immunology: In Practice

Commentary: Treatment Reduces, Exterminates Hospitalizations in Adults With Moderate to Severe AD – Consultant360

Commentary on Twitter

In Current Issue! #Dupilumab Treatment Reduces #Hospitalizations in #Adults With #Moderate– #to– #Severe #Atopic #Dermatitis https://t.co/eYqy95FADb pic.twitter.com/pRaVh9tw4S

— JACI In Practice (@JACIInPractice) May 10, 2022